Selection of euploid blastocysts for cryopreservation with array comparative genomic hybridization (aCGH) results in increased implantation rates in subsequent frozen and thawed embryo transfer cycles

Molecular Cytogenetics

Jiaen Liu²  Rifaat D Salem¹  Yanping Kuang³  Xiaohong Liu²  Shala A Salem¹  Zhihong Yang¹ 

[1] ART and PGD Program, Pacific Reproductive Center, Torrance, CA, USA;IVF Division, Beijing Jia En De Yun Hospital, Beijing, People’s Republic of China;Department of Assisted Reproduction, Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China

关键词: Implantation;    Cryopreservation;    Trophectoderm biopsy;    aCGH;   

Others  :  1150888
DOI  :  10.1186/1755-8166-6-32

 received in 2013-04-02, accepted in 2013-06-30,  发布年份 2013

【 摘 要 】

Background

In assisted reproductive treatments, embryos remaining after fresh embryo transfer are usually selected for cryopreservation based on traditional morphology assessment. Our previous report has demonstrated that array comparative genomic hybridization (aCGH) screening for IVF patients with good prognosis significantly improves clinical and ongoing pregnancy rates in fresh embryo transfer cycles. The current study further investigates the efficiency of applying aCGH in the selection of euploid embryos for cryopreservation as related to pregnancy and implantation outcomes in subsequent frozen embryo transfer (FET) cycles.

Methods

First-time IVF patients with good prognosis undergoing fresh single embryo transfer and having at least one remaining blastocyst for cryopreservation were prospectively randomized into two groups: 1) Group A patients had embryos assessed by morphology first and then by aCGH screening of trophectoderm cells and 2) Group B patients had embryos evaluated by morphology alone. All patients had at least one blastocyst available for cryopreservation after fresh embryo transfer. There were 15 patients in Group A and 23 patients in Group B who failed to conceive after fresh embryo transfer and completed the FET cycles. Blastocyst survival and implantation rates were compared between the two groups.

Results

There were no significant differences in blastocyst survival rates between Group A and Group B (90.9% vs. 91.3%, respectively; p >0.05). However, a significantly higher implantation rate was observed in the morphology assessment plus aCGH screening group compared to the morphology assessment alone group (65.0% vs. 33.3%, respectively; p = 0.038). There was no miscarriage observed in Group A while a 16.7% miscarriage rate was recorded in Group B (0% vs. 16.7%, respectively; p >0.05).

Conclusions

While aCGH screening has been recently applied to select euploid blastocysts for fresh transfer in young, low-risk IVF patients, this is the first prospective study on the impact of aCGH specifically on blastocyst survival and implantation outcomes in the subsequent FET cycles of IVF patients with good prognosis. The present study demonstrates that aCGH screening of blastocysts prior to cryopreservation significantly improves implantation rates and may reduce the risk of miscarriage in subsequent FET cycles. Further randomized clinical studies with a larger sample size are needed to validate these preliminary findings.

【 授权许可】

   
2013 Yang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Schoolcraft WB, Gardner DK, Lane M, Schlenker T, Hamilton F, Meldrum DR: Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertl Steril 1999, 72:604-609.
• [2]Gardner DK, Surrey E, Minjarrez D, Leitz A, Stevens J, Schoolcraft WB: Single blastocyst transfer: a prospective randomized trial. Fertil Steril 2004, 81:551-555.
• [3]Fragouli E, Wells D: Aneuploidy screening for embryo selection. Semin Reprod Med 2012, 30:289-301.
• [4]Alfarawati S, Fragouli E, Colls P, Stevens J, Gutierrez-Mateo C, Schoolcraft WB, Wells D: The relationship between blastocyst morphology, chromosomal abnormality and embryo gender. Fertil Steril 2011, 95:520-524.
• [5]Hodes-Wertz B, Grifo J, Ghadir S, Kaplan B, Laskin CA, Glassner M, Munné S: Idiopathic recurrent miscarriage is caused by aneuploid embryos. Fertil Steril 2012, 98:675-680.
• [6]Yang Z, Liu J, Collins G, Salem S, Liu X, S-Lyle S, Peck A, Sill ES, Salem R: Selection of single blastocysts for fresh transfer via stand morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012, 5:24. BioMed Central Full Text
• [7]Hassold T, Hunt P: Maternal age and chromosomally abnormal pregnancies: what we know and what we knew. Curr Opin Pediatr 2009, 21:703-708.
• [8]Kuliev A, Cieslak J, Verlinsky Y: Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenetgenome Res 2005, 111:193-198.
• [9]Bielanska M, Tan SL, Ao A: Chromosomal mosaicism throughout human preimplantation development in vitro: incidence, type, and relevance to embryo outcome. Hum Reprod 2002, 17:413-419.
• [10]Magli MC, Gianaroli L, Ferraretti AP, Lappi M, Ruberti A, Farfalli V: Embryo morphology and development are dependent on the chromosomal complement. Fertil Steril 2007, 87:534-541.
• [11]Munné S, Sandalinas M, Magli C, Gianaroli L, Cohen J, Warburton D: Increased rate of aneuploid embryos in young women with previous aneuploid conceptions. Prenat Diagn 2004, 24:638-643.
• [12]Munné S, Chen S, Colls P, Garrisi J, Zheng X, Cekleniak N, Lenzi M, Hughes P, Fischer J, Garrisi M, Tomkin G, Cohen J: Maternal age, morphology, development and chromosome abnormalities in over 6000 cleavage-stage embryos. Reprod Biomed Online 2007, 14:628-634.
• [13]Vanneste E, Voet T, Le Caignec C, Ampe M, Konings P, Melotte C, Debrock S, Amyere M, Vikkula M, Schuit F, Fryns JP, Verbeke G, D'Hooghe T, Moreau Y, Vermeesch JR: Chromosome instability is common in human cleavage-stage embryos. NatMed 2009, 15:577-583.
• [14]Wilton L: Preimplantation genetic diagnosis and chromosome analysis of blastomeres using comparative genomic hybridization. Hum Reprod Update 2005, 11:33-41.
• [15]Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A: Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004, 19:2849-2858.
• [16]Hardarson T, Hanson C, Lundin K, Hillensjö T, Nilsson L, Stevic J, Reismer E, Borg K, Wikland M, Bergh C: Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod 2008, 23:2806-2812.
• [17]Schoolcraft WB, Katz-Jaffe MG, Stevens J, Rawlins M, Munné S: Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil Steril 2009, 92:157-162.
• [18]Masternbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoever HR: In vitro fertilization with preimplantation genetic screening. N Engl JMed 2007, 357:9-17.
• [19]Masternbroek S, Twisk M, van der Veen F, Repping S: Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011, 17:454-466.
• [20]Voullaire L, Wilton L, Slater H, Williamson R: Detection of aneuploidy in single cells using comparative genomic hybridization. Prenat Diagn 1999, 19:846-851.
• [21]Wells D, Delhanty JDA: Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 2000, 6:1055-1062.
• [22]Sher G, Keskintepe L, Keskintepe M, Ginsburg M, Maassarani G, Yakut T, Baltaci V, Kotze D, Unsal E: Oocyte karyotyping by comparative genomic hybridization [correction of hybridization] provides a highly reliable method for selecting “competent” embryos, markedly improving in vitro fertilization outcome: a multiphase study. Fertil Steril 2007, 87:1033-1040.
• [23]Fragouli E, Lenzi M, Ross R, Katz-Jaffe M, Schoolcraft WB, Wells D: Comprehensive molecular cytogenetic analysis of the human blastocyst stage embryos. Hum Reprod 2008, 23:2596-2608.
• [24]Alfarawati S, Fragouli E, Colls P, Wells D: First births after preimplantation genetic diagnosis of structural chromosome abnormalities using comparative genomic hybridization and microarray analysis. Hum Reprod 2011, 26:1560-1574.
• [25]Hellani A, Abu-Amero K, Azouri J, El-Akoum S: Successful pregnancies after application of array-comparative genomic hybridization in PGS-aneuploidy screening. Reprod Biomed Online 2008, 17:814-817.
• [26]Fishel S, Gordon A, Lynch C, Ndukwe G, Kelada E, Thomton S, Jenner L, Cater E, Brown A, Garcia-Bernardo J: Live birth after polar body array comprehensive genomic hybridization prediction of embryo ploidy – the future of IVF. Fertil Steril 2010, 93:1006.e7-1006.e10.
• [27]Gutierrez-Mateo C, Colls P, Sanchez-Garcia J, Escudero T, Prates R, Ketterson K, Wells D, Munné S: Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011, 95:953-958.
• [28]Fioretino F, Spizzichino L, Bono S, Birricik A, Kokkali G, Rienzi L, Ubaldi FM, Lammarrone E, Gordon A, Pantos K: PGD for reciprocal and Robertsonian translocation using array comparative genomic hybridization. Hum Reprod 2011, 26:1925-1935.
• [29]Yang Z, Salem S, Salem-Lyle S, Bayrak A, Salem RD: Trophectoderm cells derived from blastocyst biopsy are suitable for array CGH analysis of 24 chromosomes. Fertil Steril 2011, 95(Suppl 4):S23. Abstr
• [30]Grifo JA, Hodes-Wertz B, Lee H-L, Amperloquio E, Clark-Williams M, Adler A: Single thawed euploid embryo transfer improves IVF pregnancy, miscarriage, and multiple gestation outcomes and has similar implantation rates as egg donation. J Assist Reprod Genet 2013, 30:259-264.
• [31]Treff NR, Su J, Tao X, Levy B, Scott RT: Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. Fertil Steril 2010, 94:2017-2021.
• [32]Northrop LE, Treff NR, Levy B, Scott R Jr: SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod 2010, 16:590-600.
• [33]Johnson DS, Gemelos G, Baner J, Ryan A, Cinnioglu C, Banjevic M, Ross R, Alper M, Barrett B, Frederick J, Potter D, Behr B, Rabinowitz M: Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocol. Hum Reprod 2010, 25:1066-1075.
• [34]Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott R Jr: Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fert Steril 2011, 96:638-640.
• [35]Handyside AH: PGD and aneuploidy screening for 24 chromosome by genome-wide SNP analysis: seeing the woods and the trees. Reprod Biomed Online 2011, 23:686-691.
• [36]Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott R Jr: Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum Reprod 2012, 27:1217-1222.
• [37]Sills ES, Yang Z, Walsh D, Salem S: Comprehensive genetic assessment of the human embryo: can empiric application of microarray comparative genomic hybridization reduce multiple gestation rate by single fresh blastocyst transfer? Archgynecol Obstet 2012, 286:755-761.
• [38]Harper JC, Sengupta SB: Preimplantation genetic diagnosis: State of the ART 2011. Humgenet 2012, 131:175-186.
• [39]Liu J, Sills ES, Yang Z, Salem S, Rahil T, Collins G, Liu X, Salem R: Array comparative genomic hybridization screening in IVF significantly reduces number of embryos available for cryopreservation. Clin Exp ReprodMed 2012, 39:52-57.
• [40]Sills ES, Schattman GL, Veeck LL, Liu HC, Prasad M, Rosenwaks Z: Characteristics of consecutive in vitro fertilization cycles among patients treated with follicle-stimulating hormone (FSH) and human menopausal gonadotropin versus FSH alone. Fertil Steril 1998, 69:831-835.
• [41]Kuwayama M, Vajta G, Iada S, Kato O: Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod Biomed Online 2005, 11:608-614.
• [42]deMouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, Kupka M, Nygren KG, Andersen AN: Assisted reproductive technology in Europe, 2006: results generated from European registers by ESHRE. Hum Reprod 2010, 25:1851-1862.
• [43]deMouzon J, Goossens V, Bhattacharya S, Castilla JA, Ferraretti AP, Korsak V, Kupka M, Nygren KG, Nyboe Andersen A: Assisted reproductive technology in Europe, 2007: results generated from European registers by ESHRE. Hum Reprod 2012, 27:954-966.
• [44]Ferraretti AP, Goossens V, deMouzon J, Bhattacharya S, Castilla JA, Korsak V, Kupka M, Nygren KG, Nyboe Andersen A: Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod 2012, 27:2571-2584.
• [45]Maheshwari A, Pandey S, Shetty A, Hamilton M, Bhattacharya S: Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil Steril 2012, 98:368-377.
• [46]Cobo A, Diaz C: Clinic application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril 2011, 96:277-285.
• [47]Rezazadeh VM, Eftekhari-Yazdi P, Karimian L: Vitrification versus slow freezing gives excellent survival, post warming embryo morphology and pregnancy outcomes for human cleaved embryos. Assist Reprod Genet 2009, 26:347-354.
• [48]Chang EM, Han JE, Kim YS, Lyu SW, Lee WS, Yoon TK: Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes: cycle regimens of vitrification thawed blastocyst transfer. J Assist Reprod Genet 2011, 28:369-374.
• [49]Zhu D, Zhang J, Cao S, Zhang J, Heng BC, Huang M, Ling X, Duan T, Tong GQ: Vitrified-warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles–time for a new embryo transfer strategy? Fertil Steril 2011, 95:1691-1695.
• [50]Kansal Kalra S, Ratcliffe SJ, Milman L, Gracia CR, Coutifaris C, Barnhart K: Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer. Fertil Steril 2011, 95:548-553.
• [51]Wada I, Macnamee MC, Wick K, Bradfield JM, Brinsden PR: Birth characteristics and perinatal outcome of babies conceived from cryopreserved embryos. Hum Reprod 1994, 9:543-546.
• [52]Wikland M, Hardarson T, Hillensjo T, Westin C, Westlander G, Wood M, Wennerholm UB: Obstetric outcomes after transfer of vitrified blastocysts. Hum Reprod 2010, 25:1699-1707.
• [53]Aflatoonian A, MansooriMoghaddam F, Mashayekhy M, Mohamadian F: Comparison of early pregnancy and neonatal outcomes after frozen and fresh embryo transfer in ART cycles. J Assist Reprod Genet 2010, 27:695-700.
• [54]Wang YA, Sulliban EA, Black D, Dean J, Bryant J, Chapman M: Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril 2005, 83:1650-1658.
• [55]Wennerholm UB, SoderstromAnttila V, Bergh C, Aittomaki K, Hazekamp J, Nygren KG, Selbing A, Loft A: Children born after cryopreservation of embryos of oocytes: a systematic review of outcome data. Hum Reprod 2009, 24:2158-2172.